Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Subjects

Phase 1 Not yet recruiting 24 enrolled Chengdu Kanghong Pharmaceutical Co., Ltd.

RandomizedParallel-groupTriple-blindTreatment

Summary

This study is a randomized, double-blind, placebo-controlled, parallel-group clinical trial. To preliminarily evaluate the safety and efficacy of KHN702 tablets in moderate to severe post-operative pain patients.

Timeline

Start: 2025-12
Primary completion: 2026-02
Completion: 2026-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	KHN702	Unknown	—	Oral

Indications

No indication recorded.